Published

Commentary: Psychedelic Psychiatry's Brave New World.

No abstract availability was recorded for this entry.

Open source BibTeX RIS

Bibliographic context

Journal: Frontiers in psychiatry
Date: 2020-01-01
Source: PubMed
DOI: 10.3389/fpsyt.2020.594077
PubMed: 33324259

Authors

Nobile B Olié E Courtet P

Watch author

Derived topics and classifications

psilocybin General Other

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Psychedelics and Psychotherapy: Is the Whole Greater than the Sum of its Parts?Clinical Pharmacology & Therapeutics · 2023-10-05 A Randomized, Double-Blind, Single Ascending Dose Study to Identify a Safe and Non-Psychedelic Dose of PsilocybinClinicalTrials.gov · 2026-07-17 A scoping review of mystical-type experiences and mood symptom outcomes in psychedelic therapy clinical trials: comparing life-threatening disease and depressive populationsTherapeutic Advances in Psychopharmacology · 2026-02-28 A Phase 2a, Open-label, Pilot Study to Assess the Safety and Efficacy of Oral Psilocybin (TRP-8802) Administration in Concert With Psychotherapy Among Adult Patients With Irritable Bowel Syndrome: A Randomized Delayed Treatment Control DesignClinicalTrials.gov · 2026-02-05 Psychedelic-assisted therapy: a survey on the clinical methods of Swiss physicians.Therapeutic advances in psychopharmacology · 2026-01-01 Harnessing Pharmacogenomics in Clinical Research on Psychedelic-Assisted Therapy.Clinical pharmacology and therapeutics · 2025-01-01 Evaluating the potential for psilocybin as a treatment for post-traumatic stress disorder.The Journal of pharmacology and experimental therapeutics · 2025-01-01 Clinical conceptualisation of PTSD in psilocybin treatment: disrupting a pre-determined and over-determined maladaptive interpretive framework.Therapeutic advances in psychopharmacology · 2025-01-01